Molecular chaperones regulate protein folding to maintain proper function of proteins. Misfolded or aggregated proteins induce cellular toxicity and cause degenerative diseases such as polyglutamine disease (Huntington's disease and so on), Alzheimer's disease, familial amyotrophic lateral sclerosis (ALS) and Parkinson's disease.
Terminally differentiated and non-dividing cells, such as neurons and muscles, are particularly vulnerable to the toxicity of misfolded proteins, as accumulation of misfolded and aggregated protein increases toxicity in such organs. Cell division usually dilutes the toxicity, even though the toxicity exceeds the threshold of cell death. The cells have the choice of 'active death' as a way of apoptosis, and they will be replaced with newly proliferated cells.
Although the protein aggregation and formation of inclusion bodies are commonly observed among these diseases, recent reports indicated that intracellular aggregation does not confer the cellular toxicity (Saudou et al., 1998; Cummings et al., 1999; Chun et al., 2002; Watase et al., 2002) , rather the protective effect as they sequester the insoluble aggregation of mutant proteins (Arrasate et al., 2004) . Finally, Kayed et al. (2003) showed that the monomeric or oligomeric fibrous conformation of mutant proteins termed amyloid might induce neuronal toxicity, which is commonly seen among these diseases.
It has been reported that apoptotic cell death is responsible for the progression of clinical symptom of degenerative disease such as ALS (Ekegren et al., 1999; Martin, 1999 ), Huntington's disease (Bova et al., 1999 ), Parkinson's disease (Tatton, 2000; Hartmann et al., 2001 ) and Alzheimer's disease (Rohn et al., 2002; Zhao et al., 2003) . The intracerebroventricular or intrastriatal administration of caspase inhibitor (zVAD-fmk) was reported as attenuating the symptom of ALS and Huntington's disease (Ona et al., 1999; Chen et al., 2000; Toulmond et al., 2004) .
Molecular chaperones in degenerative diseases
As misfolded protein is generally believed to be a critical pathological factor of aggregation diseases, extensive research has been carried out to examine the potential roles of molecular chaperones in pathogenesis of degenerative diseases. Small heat-shock family molecular chaperones have 10 members in mammalians. Four members of small heat-shock proteins (aA-crystallin (HspB4), aB-crystallin (HspB5), Hsp27 (HspB1) and Hsp22 (HspB8)) have been found as genes responsible for human degenerative myopathy, neuropathy and congenital cataract (Table 1) . Three different mutations (R120G, Q151X and 464del) of aB-crystallin have been discovered in human myofibrillar myopathy. R120G mutation causes desmin-related myopathy, which has pathological characteristics of myofibrillar degeneration and is categorized as myofibrillar myopathy. Desminrelated myopathy is sometimes accompanied with cytosolic aggregated protein, including desmin and aBcrystallin (Vicart et al., 1998; Selcen and Engel, 2003) . The biological characterization of aB-crystallin R120G mutation has indicated that mutant protein lose chaperone activity, form aggregation alone, perturb sarcomere architecture and lose antiapoptotic activity (Bova et al., 1999; Perng et al., 1999; Maloyan et al., 2005; Treweek et al., 2005; Simon et al., 2007) . Myofibrillar myopathy is also found in homozygous deletion mouse of bag3, which is a member of the BAG family co-chaperone and a regulator of Hsp70 molecular chaperone. Skeletal muscles of bag3À/À mice exhibit the foci of myofibrillar disruption and represent an early pathological alteration with altered Z-discs and apoptotic features in muscular tissues (Homma et al., 2006) .
Heart-specific overexpression of R120G mutation of aB-crystallin indicated similar phenotype as human desmin-related myopathy and cardiac hypertrophy in mice (Wang et al., 2001) . The same group has used this transgenic mouse for analysing the biological effects of R120G mutation on apoptosis in vivo. Histological examination indicated that amyloidogenic oligomer was detected in the heart of R120G transgenic mouse, suggesting that toxic oligomer was generated by R120G mutation of aB-crystallin and causes apoptotic changes with mitochondrial dysfunction and disruption of the cytoskeletal network (Sanbe et al., 2004 Maloyan et al., 2005) .
The ocular lens is transparent and avascular tissue. Lens epithelial cells proliferate and differentiate into lens fiber cells, using similar systems such as apoptosis to eliminate organelles. Apaf1 knockout mice have abnormal lens epithelium differentiation and inhibition of apoptosis in their lenses (Cecconi et al., 1998) . DNase II-like acid DNase deficiency in mice produced congenital cataract formation with undigested DNA during lens differentiation (Nishimoto et al., 2003) . Missense mutation of aA-crystallin (HspB4) and aB-crystallin was found in familiar congenital cataracts (Table 1) . In ocular lenses, crystallin is the major protein component in differentiated lens fiber cells. Using missense mutations of aA-or aB-crystallin found in congenital cataracts, many studies have been carried out analysing the functional significance of these mutations in vitro or in vivo (Kumar et al., 1999; Liu et al., 2006b ; Singh et al., 450delA, nucleotide deletion at position 450 that resulted in a frameshift in codon 150 and produced an aberrant protein consisting of 184 residues. b 464delCTX, 2 bp nucleotide deletion at position 464 (464delCT) that generates eight missense codons (RAHHSHHP) followed by a stop codon.
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2006; Gu et al., 2008; Li et al., 2008; Xi et al., 2008) , suggesting that mutants of aA-or aB-crystallin lose their chaperone activity and antiapoptotic activity. Recently, double knockout mouse of aA-and aB-crystallin was generated. In this mouse, caspase 3 activation and increased apoptotic death were observed in lens fibers (Morozov and Wawrousek, 2006) . Knockin mice were created using aA-crystallin R49C, which indicated increasing apoptosis and congenital cataract (Xi et al., 2008) . A similar phenotype of congenital cataract was observed in homozygous deletion mice of one of the heat-shock transcription factors, heat-shock factor 4, probably due to decreased expression of g-crystallin (Fujimoto et al., 2004; Min et al., 2004) . Genetic mutation of molecular chaperones has been found in some other degenerative diseases, but the relation of these mutations and apoptotic death is not clearly described yet. Missense point mutation of Hsp22 (HspB8) and Hsp27 (HspB1) genes causes peripheral neuropathy, distal hereditary motor neuropathy or Charcot-Marie-Tooth disease (Evgrafov et al., 2004; Tang et al., 2005) . Hereditary spastic paraplegia SPG13 is characterized by spasticity and weakness of the lower limbs with neuron degeneration, and is caused by the mutation in mitochondrial chaperonin hsp60 (Kallio et al., 2002) . Mutations in the sil1 gene, a nucleotide exchange factor for Hsp70 homolog in endoplasmic reticulum (ER; also called GRP78, BiP and HSPA5), cause the autosomal recessive degenerative disease Marinesco-Sjo¨gren syndrome featuring cerebellar ataxia, myopathy and cataract (Anttonen et al., 2005; Senderek et al., 2005) .
Can molecular chaperones reverse degenerative disease in vivo?
The anti-cell death function of molecular chaperones has been studied using an animal model of Huntington's disease, spinocerebellar ataxia type I, amyotrophic lateral sclerosis (ALS), Parkinson's disease, spinobulbar muscular atrophy (SBMA) and Alzheimer's disease. Overexpression of molecular chaperones mostly reverses degenerative phenotype in vivo, but some report has negative data ( Table 2 ). For example, overexpression of Hsp70 could not reverse the progression of Huntington's disease (Hansson et al., 2003) and ALS (Liu et al., 2005) . Although Hsp27 inhibits apoptosis induced by mutant Huntingtin protein in cell culture system (Wyttenbach et al., 2002) , overexpression of Hsp27 in the mouse model for Huntington's disease did not improve the phenotype (Zourlidou et al., 2007) . The difference among these results may come from the expression level of chaperones, background of the mouse and differences in experimental approaches. Furthermore, because molecular chaperones such as Hsp70 require co-chaperones for the folding or degradation process of abnormally folded protein, overexpression of Hsp70 might not be fully effective against the diseases under certain circumstances. As phosphorylation and the following oligomerization are required for the full activity of small heat-shock proteins, the active form of small heat-shock protein may not be increased by simple transgenic methods (Zourlidou et al., 2007) . Although in vivo models show some controversial results, relatively consistent results have been reported from cellular experiments, indicating that many different molecular chaperones can suppress the apoptosis induced by mutant proteins, which make aggregation in degenerative disease (Table 3) .
For therapeutic applications, Hsp70 was linked to a cell-penetrating peptide derived from the HIV transactivator of transcription (Tat) protein. Using in vitro and in vivo system of Parkinsonism model, Tat-Hsp70 protected dopaminergic neurons against neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Nagel et al., 2008) . Arimoclomol is a co-inducer of heat-shock protein genes during cell stress, probably through Hsf1 activation. This drug delays the progression of symptoms in a mouse model of ALS, which has overexpression of SOD1 mutation (Kieran et al., 2004) , and is now under phase IIb clinical trial in human ALS. Further therapeutic approaches have been tried exploiting molecular chaperones against 'degenerative diseases' (reviewed in Muchowski and Wacker, 2005) .
The mechanism of molecular chaperones' antiapoptotic function: protein folding and degradation of misfolded protein The process of protein aggregation has multiple steps from unfolded protein, soluble oligomer to insoluble aggregation (Caughey and Lansbury, 2003) . In this process, soluble oligomer species from the Ab-peptides (amyloid precursor protein b-peptides) and other amyloidogenic peptides have common structures and toxicity (Kayed et al., 2003) . Molecular chaperones protect cells from apoptosis induced by toxic oligomers ( Table 3 ), suggesting that molecular chaperones may work prior to the composition of soluble amyloid oligomer. Wacker et al. (2004) showed that Hsp70 and Hsp40 act to partition monomeric conformation of mutant polyQ (polyglutamine) and attenuate two different oligomer formations (annular and spherical) using atomic force microscopy. Schaffar et al. (2004) used intramolecular fluorescent resonance energy transfer and reported that Hsp70 and Hsp40 inhibited the structural rearrangement of mutant Huntingtin protein, suggesting that the molecular chaperones could work on the very first step in the process of aggregation. Dedmon et al. (2005) reported that Hsp70 is bound to prefibrillar species preferentially, but not to monomeric a-Syn (a-Synuclein), and blocked the formation of a-Syn fibril. However, there is no effect of Hsp70 on the net cytotoxicity of the aggregation samples, suggesting that prefibrillar a-Syn may possess the toxicity (Dedmon et al., 2005) . The addition of Hsp70 and Hsp40 also inhibited the amyloid oligomer formation of Ab (Evans et al., 2006) and Huntingtin proteins (Muchowski et al., 2000) . The combination of Hsp70 and Hsp40 also suppressed the assembly of mutant Huntingtin into detergent-insoluble amyloid-like fibrils, and caused the formation of amorphous, detergent-soluble aggregates (Muchowski et al., 2000) . The fibril formation of Ab was also inhibited by other chaperones such as Hsp20 (Lee et al., 2005) . Interestingly, yeast prion state [PSI þ ] inheritance depends on the concentration of Hsp104. At low concentration, Hsp104 promoted the transition from oligomeric to fibrillar status of prion proteins (Shorter and Lindquist, 2004) . But both amyloidogenic oligomerization and contingent fibrillization were completely abolished by high concentration of Hsp104 (Shorter and Lindquist, 2004) . The proposed pathway and the action of molecular chaperones in fibril formation are depicted in Figure 1 .
As well as protein folding of misfolded proteins by molecular chaperones, molecular chaperones also remove the abnormal protein aggregates through the ubiquitin-proteasome pathway. Hsp40 family protein Hsj1A contains DnaJ domain and ubiquitin-interacting motifs. Overexpression of Hsj1A with Hsp70 reduced polyglutamine inclusion caused by mutant androgen receptor (containing polyglutamine repeat) of SBMA, probably by promoting ubiquitination, but not by protein folding of the substrate (Howarth et al., 2007) . Hsp70 and Hsp40 were also reported as increasing the solubility of mutant androgen receptor as well as promoting the degradation of the protein through the proteasome (Bailey et al., 2002) . Hsp90 inhibitor increases proteasome degradation of hyperphosphorylated tau protein, which is a primary component of neurofibrillary tangles in Alzheimer's disease (Dickey et al., 2006) . Overexpression of Hsp70 ameliorates phenotypes of SBMA in mice with reduction in the amounts of mutant androgen receptor . The microtubule-binding protein, tau, is accumulated and deposited in the brain of patients with Alzheimer's disease. BAG1 associates with tau protein in an Hsc70-dependent manner, and modulates the degradation of tau protein by the 20S proteasome (Elliott et al., 2007) . Small heat-shock protein Hsp27 also binds to hyperphosphorylated tau protein, and Transgenic mice, transgene is derived under the human cytomegalovirus enhancer linked to the b-actin promoter.
Molecular chaperones as regulators of cell death A Hishiya and S Takayama reduces its concentration through the ubiquitin-proteasome system (Shimura et al., 2004a) . CHIP is an E3 ubiquitin ligase and interacts with the C-terminal portion of Hsp70, linking protein folding and ubiquitin-proteasome protein degradation systems (reviewed in McDonough and Patterson, 2003) . Miller et al. (2005) reported that CHIP suppressed the polyglutamine aggregation and toxicity in culture cells. They also showed its protective effect using the zebrafish model (Miller et al., 2005) . CHIP is found in the aggregation containing tau protein, and serves E3 ubiquitin ligase activity toward tau protein (Hatakeyama et al., 2004; Petrucelli et al., 2004; Shimura et al., 2004b) . CHIP also promoted the ubiquitination and degradation of mutant ataxin-1 (Al-Ramahi et al., 2006) and ataxin-3 . Overexpression of CHIP reduced motor symptoms and inhibited the accumulation of nuclear aggregation with degradation of mutant AR in a transgenic mouse model of SBMA (Adachi et al., 2007) . Mutant Ataxia-1 is a polyglutamine protein that causes spinocerebellar ataxia type I. Using the Drosophila model of neurodegeneration, overexpression of CHIP reduces the toxicity of mutant ataxin-1 through direct interaction and ubiquitination of mutant ataxin-1 (Al-Ramahi et al., 2006) . CHIP was also reported as an interacting partner of co-chaperone BAG1 and BAG2 for regulating misfolding-dependent protein degradation with Hsp70 (Demand et al., 2001; Arndt et al., 2005; Dai et al., 2005) . Recently, the relationship between molecular chaperones and autophagy has been extensively studied. HspB8, one of the small heat-shock proteins, forms a stable complex with BAG3, and this complex accelerates the degradation of mutant Huntingtin protein through autophagy (Carra et al., 2008) .
Ischemic diseases
Pathological examination of ischemic lesions indicates two types of cell death, necrosis and apoptosis. It has been reported that inhibition of apoptotic pathways by caspase inhibitors (XIAP and NAIP) or overexpression of antiapoptotic protein (Bcl-2) in animal models of ischemic brain injury protects neurons from apoptosis (Martinou et al., 1994; Linnik et al., 1995; Xu et al., 1997 Xu et al., , 1999 Kitagawa et al., 1998; Hata et al., 1999; Trapp et al., 2003) . Molecular chaperones have also been reported as antiapoptotic in cell culture models or animal models of ischemia-induced apoptosis. In this section, we will review molecular chaperones in the regulation of ischemia-induced apoptosis and summarize how the potential mechanisms of molecular chaperones protect cells from apoptosis in ischemia. Abbreviation: NA, not applicable.
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The expression of molecular chaperones It has been reported that synthesis of inducible forms of a major molecular chaperone, Hsp70, is increased following transient ischemic stress in the brain Nishi et al., 1993; Sharp et al., 1993; Gaspary et al., 1995) , heart (Dillmann et al., 1986; Mehta et al., 1988; Knowlton et al., 1991) , liver (Boeri et al., 2003; Kuboki et al., 2007) and kidney . To examine the effect of overexpression of Hsp70 in animal models of ischemic injury, three different methods were used: whole body heat stress (Marber et al., 1994) , overexpression of molecular chaperones using viral vector (Yenari et al., 1998; Hoehn et al., 2001; Kelly et al., 2002) and transgenic animals expressing molecular chaperones (brain (Plumier et al., 1997; Rajdev et al., 2000; Tsuchiya et al., 2003a, b; Matsumori et al., 2005) and heart (Marber et al., 1995; Plumier et al., 1995; Radford et al., 1996; Trost et al., 1998) ). From these animal studies, overexpression of Hsp70 reduces ischemia-induced tissue injury in the brain (Plumier et al., 1997; Yenari et al., 1998; Rajdev et al., 2000; Hoehn et al., 2001; Kelly et al., 2002; Tsuchiya et al., 2003a; Matsumori et al., 2005) , heart (Marber et al., 1995; Plumier et al., 1995; Radford et al., 1996; Trost et al., 1998; Suzuki et al., 2002) and liver (Kuboki et al., 2007) . Reduced Hsp70 expression level induces more infarction volume of focal cerebral ischemia in knockout mice of hsp70.1 (gene encoding inducible Hsp70) (Lee et al., 2001 (Lee et al., , 2004 . Overexpression of Hsp27 and aB-crystallin (HspB5) in transgenic mice showed a reduced amount of infarction (Ray et al., 2001; Efthymiou et al., 2004) and attenuated cardiomyocyte apoptosis (Ray et al., 2001) . In the heart of double knockout mice of aB-crystallin and HspB2, which have shared regulatory elements in the promoter region, ischemia-reperfusion exhibits contractile dysfunction and increased myocardial infarction ( Figure 1 Proposed pathway in amyloid assembly and actions of molecular chaperones. Mutated proteins form an abnormal conformation (misfolded monomer), followed by oligomerization. Several types of oligomer conformation were confirmed (for example, annular oligomer, spherical oligomer, amorphous aggregate and protofibril). Soluble oligomers share the common toxic conformation (Kayed et al., 2003) . Molecular chaperones prevent the formation of toxic oligomers from misfolded monomer. Molecular chaperones also promote the toxic oligomer to the fibril-type aggregation, which has less toxicity and stable.
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A Hishiya and S Takayama overexpression of Hsp60 also showed neuroprotection of CA1 pyramidal neurons from ischemic damage (Hwang et al., 2007) . The roles of molecular chaperones on antiapoptotic effect against ischemic stress were summarized in Table 4 . Lee et al. (2004) directly showed the antiapoptotic effect of Hsp70 in focal cerebral ischemia using gene knockout mice. In contrast, apoptosis was attenuated in transgenic mice of Hsp70 during cerebral ischemia and reperfusion (Tsuchiya et al., 2003a, b) .
Antiapoptotic function
As an in vitro experiment, overexpression of Hsp70 inhibits apoptosis induced by ischemic stress in cardiomyocytes (Suzuki et al., 2002) , astrocytes (Papadopoulos et al., 1996) and kidney cells (Meldrum et al., 2001) . The mitochondrial chaperones Hsp60 and Hsp10 also protected cells from ischemic stress-induced apoptosis in cardiomyocytes (Lau et al., 1997; Lin et al., 2001) . The inhibition of ischemia-induced apoptosis by Hsp70 was demonstrated using transgenic mice overexpressing rat Hsp70 (Tsuchiya et al., 2003a, b) and hsp70.1 gene deletion mice (Lee et al., 2004) . Herpes simplex virusmediated overexpression of Hsp70 improved neuronal survival in a rat model of ischemic brain injury (Yenari et al., 1998; Kelly et al., 2002) . Pharmacological inhibitor of Hsp90, geladanamycin, induces Hsp70 expression and reduced ischemia-induced apoptosis in vivo and in vitro (Lu et al., 2002; Xu et al., 2003) .
The mechanism of antiapoptosis After ischemic damage, reactive oxygen species increase mitochondrial pathways of apoptotic signals, releasing cytochrome c, caspase 9 and the second mitochondriaderived activator of caspases (Smac). SOD (copper/zinc superoxide dismutase) has an important function in attenuating ischemic stress in mitochondria (Suzuki et al., 1999) . Using transgenic rats overexpressing SOD, ischemia-induced hippocampal CA1 neurons were protected from apoptosis by the suppression of superoxide production, cytochrome c and Smac release (Sugawara et al., 2002) . Mitochondrial Hsp70 (Hsp75/ Grp75) inhibited apoptosis induced by oxygen-glucose deprivation or glucose deprivation in primary astrocytes (Voloboueva et al., 2008) or ischemia reperfusion in cardiomyocytes (Williamson et al., 2008) with decreased reactive oxygen species. Overexpression of Hsp70 in isolated rat hearts inhibited apoptosis after ischemia reperfusion while improving the activity and amount of SOD (Suzuki et al., 2002) . PEP-1-Hsp27 (amphipathic peptide carrier conjugated Hsp27 for the delivery into cells) also protected astrocytes from apoptosis induced Wang et al. (1999) Abbreviation: I/R, ischemia and reperfusion.
a Transgenic mice, transgene is derived under the human cytomegalovirus enhancer linked to the b-actin promoter.
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by oxidative stress in vitro as well as in vivo with decreasing lipid peroxidation . There are several reports indicating the accumulation of protein aggregation and ubiquitination, a hallmark of cellular response against misfolded proteins, after ischemic stress (Hu et al., 2000; Ouyang and Hu, 2001; Giffard et al., 2004) , suggesting that molecular chaperones have functions in regulating protein folding and aggregation during ischemic stress. Hsp70 transgenic mice (cytomegalovirus enhancer and chicken b-actin promoter) have been used for ischemia-reperfusion injury experiments, and significant neuroprotection was observed with the inhibition of apoptosis (Tsuchiya et al., 2003a, b) . In this model, after ischemia reperfusion, Hsp70 is bound to AIF (apoptosis-inducing factor) in cytosol and prevented the nuclear translocation of AIF (Matsumori et al., 2005) . BAX translocation from cytosol to mitochondria is regulated by Hsp60, which binds to BAX in cytosol and inhibits translocation of BAX to mitochondria. BAX dissociates from Hsp60, and translocates to the mitochondria of adult cardiomyocytes under hypoxic conditions (Gupta and Knowlton, 2002) .
Cancer
Since molecular chaperones were discovered, elevated expression of molecular chaperones has been widely reported in cancer tissues and cells, suggesting the contribution of aberrant expression of heat-shock proteins to tumorigenesis (reviewed in Jaattela, 1999) .
The high expression of molecular chaperones is induced by physiological stress, which is caused by a shortage of oxygen, nutrition or other essential molecules from their proliferative activity. Additionally, tumor cells have to maintain the high turnover of DNA replication, RNA transcription and protein translation.
Tumor transformation has a selective advantage in terms of proliferation, antiapoptosis and against other physiological stress. In this context, molecular chaperones have oncogenic activity. Forced expression of Hsp70 in Rat-1 cells transformed the cells in terms of loss of contact inhibition and formation of foci (Volloch and Sherman, 1999) . Transgenic mice expressing Hsp70 under insulin promoter (where transgene was also expressed in T cells) developed T-cell lymphoma (Seo et al., 1996) . In this section, we will focus on the correlation of molecular chaperones and apoptosis in tumor cells.
Antiapoptotic function of molecular chaperones in tumor cells
The antiapoptotic function of molecular chaperones in tumor cells has been reported (Table 5) . Hsp70 is strongly induced in pancreatic adenocarcinoma cell lines, and inhibition of the expression by quercetin, one of the most active flavonoids, or RNAi, resulted in the prominent apoptosis of cells (Aghdassi et al., 2007) .
Quercetin also decreased the size of intraperitoneal xenograft tumor of MiaPaCa-2 tumor cells (pancreatic adenocarcinoma cancer cells) in vivo (Aghdassi et al., 2007) . The diminished expression of Hsp70 by triptolide, a small molecule discovered from the Chinese plant Tripterygium wilfordii, also resulted in the passive apoptosis of pancreatic cancer cells in vivo as well as in vitro . The suppression of Hsp110 expression by RNAi also enhanced apoptosis in cancer cells, but not in normal cells (Hosaka et al., 2006) .
The mechanism of antiapoptosis Protein folding. Primary structure (peptide sequences) determines the final conformation of protein (Anfinsen's dogma), concluded from the result of Anfinsen's experiment 'enzymatic activity of ribonuclease was preserved after denature and renature cycle in vitro'. Are all mutated proteins unfolded? The genomic instability is commonly observed in cancer cells, resulting in amino-acid substitution and deletion. Thus, it is expected that cancer cells have abnormally folded proteins due to genetic mutations, but mutated protein can get proper folding by molecular chaperones. Blagosklonny et al. (1996) reported that p53 mutant (p53V143A) failed to obtain or stabilize correct conformation without functional Hsp90, suggesting that molecular chaperones can make mutant proteins survive in cancer cells. In the bacterium Salmonella typhimurium, a decreased level of fitness was observed when mutations were accumulated (Maisnier-Patin et al., 2005) . Intriguingly, levels of the heat-shock proteins DnaK and GroEL were increased in lineages harboring many mutations, and the overexpression of GroEL further increased the fitness of lineages (Maisnier-Patin et al., 2005) . The overexpression of GroEL in Escherichia coli attenuated the growth retardation caused by harmful mutations as well (Fares et al., 2002) . Induction of molecular chaperones is beneficial for the survival of cancer cells as well as bacterial cells.
ER stress. Because of highly proliferative growth, tumor cells are under hypoxia and hyponutrition until they can further acquire the additional ability of either angiogenesis or infiltration to another tissue. Furthermore, tumor cells have to meet the demand of high expression of proteins, translation of RNA and replication of DNA because of their highly proliferating growth. These stressful conditions easily cause ER stress, which is originated from ER. Membrane or secretary proteins, which have signal sequence or signal patch, are translated, folded and modified in ER. Cells tightly regulate the process of protein synthesis and maturation, and only properly folded proteins can be transported to the next organelle, the Golgi apparatus. The disruption of ER functions, such as malnutrition, hypoxia, hypoglycosylation, virus infection and unbalanced Ca 2 þ homeostasis, can induce the accumulation of misfolded proteins in ER lumen and ER stress. Unfolded protein in ER is sensed by three major ER membrane proteins, PERK, ATF6 and IRE, followed by the activation of several pathways called unfolded protein response, which induce transient attenuation of protein translation, increase folding activity by the induction of molecular chaperones and degradation of malfolded protein by ubiquitin-proteasome machinery ER-associated degradation (ERAD). But when abnormal proteins are still persisting or exceed the capacity in ER, apoptotic cascade is activated. Because of limitation of space, please refer other review articles for ER stressinduced apoptosis (Xu et al., 2005) , in cancer (Moenner et al., 2007) , in neurodegenerative diseases (Lindholm et al., 2006) , in diabetes mellitus (Eizirik et al., 2008) and ischemia (DeGracia and Montie, 2004) .
From the Hsp70 family of molecular chaperone proteins, glucose-regulated protein 78 (Grp78) is one of the best characterized ER chaperone proteins, which is involved in ER function and has an antiapoptotic function in tumor cells (Jamora et al., 1996; Suzuki et al., 2007) . The antiapoptotic mechanism of Grp78 may fall into two main pathways. Because of its chaperone function, Grp78 directly works on protein folding, and attenuates ER stress. On the other hand, as Grp78 also serves as a sensor for ER stress, the accumulation of misfolded proteins in ER lumen keeps Grp78 away from IRE, PERK and ATF6, which results in the activation of these membrane proteins, and is followed by unfolded protein response or apoptosis. The overexpression of Grp78 has been observed in many tumor cell types, and protects tumor cells against apoptosis, especially in the presence of anticancer therapeutic drugs (doxorubicin, taxol, cisplatin and so on) (reviewed in Li and Lee, 2006) . Luo et al. (2006) showed that grp78-deficient mice were embryonically lethal with massive apoptosis when they are 3.5 days old, suggesting the antiapoptotic function of Grp78. In fact, cancer progression was significantly attenuated with reduction of tumor cell proliferation, inhibition of tumor angiogenesis and massive apoptosis in tumor cells in grp78 heterozygous mice, in which the expression level of Grp78 is reduced by about half (Dong et al., 2008) . The quality control of ER protein is tightly regulated by ER chaperones, and abnormal function of ER chaperones induces apoptosis. As described in Table 6 , we summarized apoptosis-related phenotypes in genetic disease of molecular chaperones including ER chaperones.
Direct inhibition of an apoptotic pathway
In the mitochondrial pathway, cell death signals induce the release of cytochrome c, Smac/DIABLO or AIF. Small heat-shock proteins, Hsp27, inhibit apoptosis by directly binding to cytosolic cytochrome c and sequestering Apaf1 (Garrido et al., 1999; Bruey et al., 2000) . A recent report indicated that Hsp27 also inhibited Smac release from mitochondria (Chauhan et al., 2003) .
Molecular chaperone Hsp70 inhibits apoptosome formation by direct binding to Apaf1 (Beere et al., ADD70, a peptide containing the AIF sequence involved in its interaction with Hsp70. Quercetin, a widely distributed bioflavonoid that inhibits heat-shock protein induction (not related to HSF1 activity). Triptolide, a diterpene triepoxide from the plant Triptergium wilfordii, which is highly effective in inhibiting Hsp70 expression. REG and PRO, a sub-population of a chemically induced rat colon carcinoma selected and isolated according to their susceptibility to trypsin-mediated detachment from plastic surfaces (Martin et al., 1983) . PRO gives rise to progressive tumors in most of the animals, whereas REG gives rise to no tumors or to tumors that regress in less than 30 days (Caignard et al., 1985) . Molecular chaperones as regulators of cell death A Hishiya and S Takayama 2000; Saleh et al., 2000) . Another report has negative observation about the involvement of Hsp70 in the regulation of apoptosomes. High salt concentration (from the preparation of recombinant Hsp70) itself is enough for the inhibition of apoptosome (Steel et al., 2004) . A recent report indicated that Hsp70 and tumor suppressor protein PHAPI and CAS (cellular apoptosis susceptibility protein) stimulate the apoptosome by promoting nucleotide exchange of Apaf1 . The function of Hsp70 in apoptosome is to promote apoptosome activity. Hsp70 directly binds to AIF and inhibits AIFdependent caspase-independent apoptosis (Ravagnan et al., 2001) . A peptide containing the AIF sequence involved in its interaction with Hsp70 induced apoptosis in both rat colon cancer cells and mouse melanoma cells under cisplatin stimuli (Schmitt et al., 2006) . Nylandsted et al. (2000) reported that Hsp70 inhibited apoptosis in human breast tumor cells, but it was neither dependent on caspases nor on p53, suggesting versatile functions of Hsp70 or the function in the downstream of unknown caspases. Endonuclease G (EndoG) is a mitochondrial enzyme that has nuclease activity and is induced by apoptotic signals. Hsp70 binds to EndoG and AIF, preventing DNase activity (Kalinowska et al., 2005) . Takada et al. (2003) Abbreviations: CNS, central nervous system; DRM, desmin-related myopathy; TNFa, tumor necrosis factor-a.
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Bax translocates to the mitochondria and participates in apoptosis induction. Heat-shock proteins have been reported as inhibitors of Bax translocation. Hsp27 inhibits bax translocation from cytosol to mitochondria through the PI3 kinase-dependent Akt pathways (Havasi et al., 2008) . Hsp70 is also reported as an inhibitor of Bax translocation (Stankiewicz et al., 2005) . Regulation of ischemia-induced apoptosis by Hsp60 in bax translocation was described above. Recently, cytokineinduced destabilization of mRNA of BH3-only Bcl-2 family protein, Bim, is reported as directly regulated by Hsc70 and its co-chaperones, BAG4, CHIP, HIP and Hsp40 (Matsui et al., 2007) . Co-chaperone, CHIP E3 ligase is also reported as a ubiquitinating protein in apoptosis signaling and inhibits apoptosis, such as Ask1 (apoptosis signal-regulating kinase) and DAPK (death-associated protein kinase) (Hwang et al., 2005; Zhang et al., 2007) .
Conclusions
Molecular chaperones have critical function in protein folding, protein degradation and cell death. CHIP was found as a co-chaperone of Hsp70 and a ubiquitin ligase targeting abnormal proteins, which failed to be refolded by Hsp70. Recent reports indicated that ubiquitinproteasome degradation of apoptosis-related signal is also directly regulated by CHIP. Thus, CHIP or other chaperone-associating ubiquitin-proteasome-related proteins might have critical functions in regulating apoptosis when unfolded or aggregated protein is accumulated in cells. Therefore, research in the mechanism of regulating 'fold or degradation' decision by molecular chaperones and their co-chaperones may give us more precise mechanism of molecular chaperone function in regulating apoptotic signals.
